文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.

作者信息

Feng Chenchen, Li Yuqing, Li Kunping, Lyu Yinfeng, Zhu Wenhui, Jiang Haowen, Wen Hui

机构信息

Department of Urology, Huashan Hospital, Fudan University, 12 Middle Urumqi Rd, 200040, Shanghai, PR China.

Institute of Urology, Fudan University, 200040, Shanghai, PR China.

出版信息

J Exp Clin Cancer Res. 2021 Dec 2;40(1):379. doi: 10.1186/s13046-021-02165-5.

DOI:10.1186/s13046-021-02165-5
PMID:34857034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8638483/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4749/8638483/4ea4b552461f/13046_2021_2165_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4749/8638483/4ea4b552461f/13046_2021_2165_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4749/8638483/4ea4b552461f/13046_2021_2165_Fig1_HTML.jpg

相似文献

[1]
Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.

J Exp Clin Cancer Res. 2021-12-2

[2]
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.

Mol Metab. 2018-12-5

[3]
Investigation of Metabolomic Changes in Sunitinib-Resistant Human Renal Carcinoma 786-O Cells by Capillary Electrophoresis-Time of Flight Mass Spectrometry.

Biol Pharm Bull. 2018

[4]
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.

Oncotarget. 2015-5-30

[5]
Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.

PLoS One. 2015-6-26

[6]
Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma.

Exp Cell Res. 2017-9-15

[7]
Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC).

Cancers (Basel). 2021-8-31

[8]
CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation.

PLoS One. 2020-5-15

[9]
Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma.

J Cancer. 2019-6-9

[10]
RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.

Exp Cell Res. 2018-9-27

引用本文的文献

[1]
Sulforaphane-cysteine inhibits α-tubulin/PD-L1/PFKFB4 axis leading to apoptosis in human glioblastoma.

Med Oncol. 2025-7-14

[2]
CD151 interacts with integrin beta 2 in B cell lymphomas.

Cell Mol Life Sci. 2025-6-4

[3]
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma.

Cell Death Discov. 2025-4-19

[4]
Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism.

Int J Gen Med. 2022-8-2

本文引用的文献

[1]
PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.

J Exp Clin Cancer Res. 2021-9-30

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索